NSE filing, NSE: AUROPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Aurobindo Pharma Ltd: key numbers
- Share price
- ₹1,705.00
- Market cap
- ₹99,027 Cr
- Revenue (annual)
- ₹33,653 Cr
- Net profit (annual)
- ₹3,505 Cr
- P/E (TTM)
- 25.1×Sector 41.3×
- Promoter holding
- 51.88%+0.00% QoQ
- FII holding
- 17.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aurobindo Pharma Ltd
All →Aurobindo Pharma Management Change
Aurobindo Pharma's board approved reappointing independent director Mangalam Ramasubramanian Kumar for a second five-year term from April 1, 2027. Shareholder approval by postal ballot is required.
- Execution
- Five years from April 1, 2027
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Aurobindo Pharma Dividend
Aurobindo Pharma declared an interim dividend of Rs 7.00 per share for FY27. Record date is 11 November 2026, with payment on or before 20 November.
Aurobindo Pharma Investor Presentation: Key Takeaways
Q2FY27 revenue ₹10,263 Cr (+23.9% YoY), record EBITDA ₹2,156 Cr at 21.0% margin, PAT ₹1,124 Cr (+32.5% YoY). Lannett acquisition completed.
Aurobindo Pharma Results Update
Aurobindo Pharma reported Q2 FY27 revenue of Rs.10,263 Crore, up 23.9% YoY, and net profit of Rs.1,124 Crore. An interim dividend of Rs.7 per share was declared.
Aurobindo Pharma Q2 FY27 Results: Net Profit ₹1,124 Cr, Up 32.5% YoY
Aurobindo Pharma Ltd reported revenue from operations of ₹10,263 Cr (+23.9% YoY) and net profit of ₹1,124 Cr (+32.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,124 Cr · +32.5% YoY
Other acquisition announcements
All →Shree Tirupati Balajee FIBC Acquisition Worth ₹35.5 Cr
The company approved up to Rs 35.5 Crore investment in unlisted Stable Textile Private Limited. It is a related-party deal.
- Value
- ₹35.50 Cr
Choice International Acquisition
Choice International acquired 100% stakes in Truestock Universe and Quanthm Bit Works for Rs.10,000 each, entering digital/technology space. Its material subsidiary CCSPL also sold its entire stake in SKP Green Ventures, making it a step-down subsidiary.
Pajson Agro India Acquisition Worth ₹354.5 Cr
Pajson Agro's board approved acquiring 100% of Pacific Global FZCO for Rs 354.52 Crore via share swap. A preferential issue and EGM on December 4 follow.
- Value
- ₹354.5 Cr
Gujarat Fluorochemicals Acquisition Worth ₹600 Cr
Gujarat Fluorochemicals approved a Rs 600 Crore cash investment in its subsidiary GFCL EV Products, to be paid in tranches over FY 2026-27. The transaction is classed as a related-party deal and is not material.
- Value
- ₹600.0 Cr
- Execution
- FY 2026-27
Mafatlal Industries Acquisition Worth ₹0.25 Cr
Mafatlal Industries' board approved buying a 20% stake in its subsidiary PSPL from an existing shareholder for Rs. 25 lakh. The company's holding rises from 60% to 80%.
- Value
- ₹0.25 Cr
- Execution
- Within thirty (30) days
Physicswallah Acquisition Worth ₹0.03 Cr
Physicswallah will acquire 25,599 shares, or 12.25%, of subsidiary Utkarsh Classes for ₹2,55,990 under a fixed-price amendment. Its stake rises from 75.50% to 87.75%.
- Value
- ₹0.03 Cr
- Execution
- Three months